VERTEX PHARMACEUTICALS INCORPORATED

Lobbying client · Massachusetts · filed 2025 to 2026

Biopharmaceutical manufacturer.

$340,000 Reported spend

7 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (65129), not by name.

Firms hired 1

MARSHALL & POPP, LLC $340,000 7 filings

Bills named in these filings 3

HR 1227
Alternatives to PAIN Act

6 filings
S 475
Alternatives to PAIN Act

6 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

1 filing

Reported by year 2 years

2026 $120,000 2 filings
2025 $220,000 5 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Centers For Medicare and Medicaid Services (CMS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
White House Office 6
Natl Economic Council (NEC) 1

Recent filings 7 total

Q2

MARSHALL & POPP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 9, 2026

View → Q1

MARSHALL & POPP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 17, 2026

View → Q4

MARSHALL & POPP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 16, 2026

View → Q3

MARSHALL & POPP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 20, 2025

View → Q2

MARSHALL & POPP, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 21, 2025

View → Q1

MARSHALL & POPP, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 21, 2025

View → RR

MARSHALL & POPP, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 24, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.